Regulatory Affairs

AHRA Advocacy

About AHRA Regulatory Affairs

The role of the AHRA Regulatory Affairs Committee is to help our members understand, navigate and implement new or changing regulations that affect our industry and specifically, the medical imaging community. Consistent with the goals of AHRA's Strategic Plan, through participation and interaction with a variety of influential national organizations and alliances, we endeavor to expand awareness of AHRA's presence and participation within the healthcare space as an important and influential industry leader.

The mission of AHRA's Regulatory Affairs Committee is to use a systematic approach to evaluate proposed legislation, regulations and budget rules that impact medical imaging. The Committee may also evaluate alliances, partnerships, or coalitions. Existing arrangements will be evaluated annually to ensure that partnerships, alliances, or coalitions further the goals of the organizations stated in the Strategic Plan. All alliances, partnerships or coalitions must include activities to promote the goals of the AHRA. Have a regulatory question? Ask your fellow AHRA Members in the Regulatory and Reimbursement community in Connect!

Health Policy Newsletter

Robert F. Kennedy Jr. and Dr. Oz Nominated for Prominent Health Policy Roles

President-elect Trump is actively organizing his Cabinet for his second presidential term. Each Cabinet nominee must receive a simple majority in the Senate to be confirmed. In cases of a 50-50 tie, the Vice President casts the deciding vote, meaning nominees will need at least 50 votes for confirmation as Vice President Vance would break a tie.

Read More

Previous Newsletters

Latest News

HHS Finalizes Sweeping Non-Discrimination Rule

The Department of Health and Human Services (HHS), through the Office of Civil Rights (OCR) recently released a final rule regarding section... Read More

Official Communications & Comment Letters

2024 IPPS Proposed Rule

2024 OPPS Comments

2024 PFS Comments

View More